These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26590797)

  • 1. Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells.
    El-Awady RA; Semreen MH; Saber-Ayad MM; Cyprian F; Menon V; Al-Tel TH
    DNA Repair (Amst); 2016 Jan; 37():1-11. PubMed ID: 26590797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M; Esmaeili-Mahani S
    Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
    Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
    Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
    Tun JO; Salvador-Reyes LA; Velarde MC; Saito N; Suwanborirux K; Concepcion GP
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells.
    Kim HJ; Min A; Im SA; Jang H; Lee KH; Lau A; Lee M; Kim S; Yang Y; Kim J; Kim TY; Oh DY; Brown J; O'Connor MJ; Bang YJ
    Int J Cancer; 2017 Jan; 140(1):109-119. PubMed ID: 27501113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDRI-9: a novel DNA damage response inhibitor that blocks mitotic progression.
    Jun DW; Hwang M; Kim YH; Kim KT; Kim S; Lee CH
    Oncotarget; 2016 Apr; 7(14):17699-710. PubMed ID: 26848527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel carbazole derivative, MHY407, sensitizes cancer cells to doxorubicin-, etoposide-, and radiation treatment via DNA damage.
    Yoon S; Kim JH; Lee YJ; Ahn MY; Choi G; Kim WK; Yang Z; Lee HJ; Moon HR; Kim HS
    Eur J Pharmacol; 2012 Dec; 697(1-3):24-31. PubMed ID: 23085270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
    Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
    Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cells.
    Seoane S; Montero JC; Ocaña A; Pandiella A
    J Natl Cancer Inst; 2010 Sep; 102(18):1432-46. PubMed ID: 20811002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roscovitine modulates DNA repair and senescence: implications for combination chemotherapy.
    Crescenzi E; Palumbo G; Brady HJ
    Clin Cancer Res; 2005 Nov; 11(22):8158-71. PubMed ID: 16299248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
    Nam AR; Jin MH; Park JE; Bang JH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):1167-1179. PubMed ID: 30514066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.
    Wang FZ; Fei HR; Cui YJ; Sun YK; Li ZM; Wang XY; Yang XY; Zhang JG; Sun BL
    Apoptosis; 2014 Sep; 19(9):1389-98. PubMed ID: 24928205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells.
    Zhou Y; Pan DS; Shan S; Zhu JZ; Zhang K; Yue XP; Nie LP; Wan J; Lu XP; Zhang W; Ning ZQ
    Biomed Pharmacother; 2014 May; 68(4):483-91. PubMed ID: 24721323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma.
    Weng MT; Tung TH; Lee JH; Wei SC; Lin HL; Huang YJ; Wong JM; Luo J; Sheu JC
    Sci Rep; 2015 Apr; 5():9357. PubMed ID: 25880358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy.
    Pfitzer L; Moser C; Gegenfurtner F; Arner A; Foerster F; Atzberger C; Zisis T; Kubisch-Dohmen R; Busse J; Smith R; Timinszky G; Kalinina OV; Müller R; Wagner E; Vollmar AM; Zahler S
    Cell Death Dis; 2019 Apr; 10(4):302. PubMed ID: 30944311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.
    Mack PC; Gandara DR; Lau AH; Lara PN; Edelman MJ; Gumerlock PH
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):337-48. PubMed ID: 12721762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of interaction between butyroyloxymethyl-diethyl phosphate (AN-7) and doxorubicin in MCF-7 and resistant MCF-7/Dx cell lines.
    Engel D; Nudelman A; Levovich I; Gruss-Fischer T; Entin-Meer M; Phillips DR; Cutts SM; Rephaeli A
    J Cancer Res Clin Oncol; 2006 Oct; 132(10):673-83. PubMed ID: 16826403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
    Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
    Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
    Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
    Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.